Free signup for more
- Track your favorite companies
- Receive email alerts for new filings
- Personalized dashboard of news and more
- Access all data and search results
Key to changes
?
Text removedfrom 2023 Q1- Text added to 2023 Q2
Content analysis
?Positive | |
Negative | |
Uncertain | |
Constraining | |
Legalese | |
Litigous | |
Readability |
H.S. freshman Avg
|
Content analysis
?Positive | |
Negative | |
Uncertain | |
Constraining | |
Legalese | |
Litigous | |
Readability |
H.S. sophomore Avg
|
New words:
adjourned, answer, CSRP, Disease, EGBU, epidemic, EVU, formal, object, Objecting, objection, Operand, passing, Peyronie, premium, proof, Reconstruction, reversionary, robust, strong, tentative, unlimited
Removed:
Dohme, ertapenem, evolving, exploring, Invanz, Merck, Sharp
Valuein 2023 Q1 filing- Value in 2023 Q2 filing
Original filings
Filing view